Biller Jonathan

EVP and Chief Legal Officer

Biller Jonathan has filed 7 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Feb 26, 2026.

On the most recent filing, Biller Jonathan is listed as EVP and Chief Legal Officer at VERTEX PHARMACEUTICALS INC / MA. Inside the rolling window, Biller Jonathan reported no open-market purchases and 7 open-market sales totaling $4.1M in VRTX. The largest disclosed transaction in the window is a sale of 2,476 VRTX shares on Feb 17, 2026, worth $1.2M.

Companies traded

Other insiders at VRTX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$4.1M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
VRTXSale$460KFeb 26SEC ↗
VRTXSale$1.2MFeb 19SEC ↗
VRTXSale$589KFeb 19SEC ↗
VRTXSale$493KFeb 18SEC ↗
VRTXSale$886KFeb 12SEC ↗
VRTXSale$156KDec 5SEC ↗
VRTXSale$281KOct 3SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Biller Jonathan made?

Biller Jonathan has filed 7 SEC Form 4 filings (15 transaction rows) across 1 company since 2025.

Which companies does Biller Jonathan trade?

Biller Jonathan has filed SEC Form 4 disclosures for 1 company, including VRTX.

When was Biller Jonathan's most recent SEC Form 4 filing?

Biller Jonathan's most recent SEC Form 4 filing on Tracefour is dated Feb 26, 2026.

What is Biller Jonathan's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Biller Jonathan is listed as EVP and Chief Legal Officer.

What is Biller Jonathan's total buy and sell value in the current window?

Inside the rolling retention window, Biller Jonathan bought $0 and sold $4.1M based on SEC Form 4 filings.

What was Biller Jonathan's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 2,476 VRTX shares on 2026-02-17, worth $1.2M, per SEC Form 4 filings.